| Dr Sylvia Yolanda Rodriguez, PHARMD | |
|
1510 San Pablo St, Suite 144, Los Angeles, CA 90033-5320 | |
| (323) 442-5770 | |
| (323) 442-5970 |
| Full Name | Dr Sylvia Yolanda Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 1510 San Pablo St, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114370129 | NPI | - | NPPES |
| 35716 | Other | CA | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 35716 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sylvia Yolanda Rodriguez, PHARMD 1510 San Pablo St, Suite 144, Los Angeles, CA 90033-5320 Ph: (323) 442-5770 | Dr Sylvia Yolanda Rodriguez, PHARMD 1510 San Pablo St, Suite 144, Los Angeles, CA 90033-5320 Ph: (323) 442-5770 |
News Archive
Patients with epilepsy often undergo evaluation by concurrent video and EEG monitoring (vEEG) for therapeutic planning, including possible epilepsy surgery. Seizures during monitoring increase the diagnostic yield and requires the withdrawal of anticonvulsant drugs (AEDs) to allow seizures to occur.
​Clues left at the scene of the crime don't always point to the guilty party, as EPFL researchers investigating Parkinson's disease have discovered. It is generally accepted that the disease is aggravated when a specific protein is transformed by an enzyme.
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.
Young people seeking help who are at high risk of developing psychosis could significantly reduce their chances of going on to develop a full-blown psychotic illness by getting early access to cognitive behavioural therapy, new research shows.
› Verified 6 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |